Honz Pharmaceutical Co Ltd
SZSE:300086
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Honz Pharmaceutical Co Ltd
Other Current Liabilities
Honz Pharmaceutical Co Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Honz Pharmaceutical Co Ltd
SZSE:300086
|
Other Current Liabilities
¥167.3m
|
CAGR 3-Years
27%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Current Liabilities
¥4B
|
CAGR 3-Years
106%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Current Liabilities
¥3.9B
|
CAGR 3-Years
82%
|
CAGR 5-Years
11%
|
CAGR 10-Years
24%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Current Liabilities
¥3.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
10%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Other Current Liabilities
¥919.3m
|
CAGR 3-Years
52%
|
CAGR 5-Years
19%
|
CAGR 10-Years
22%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Other Current Liabilities
¥435.5m
|
CAGR 3-Years
74%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Honz Pharmaceutical Co Ltd
Glance View
Honz Pharmaceutical Co., Ltd. engages in the manufacture and distribution of drugs for children. The company is headquartered in Haikou, Hainan and currently employs 872 full-time employees. The company went IPO on 2010-05-26. The firm provides western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant and arresting convulsion drugs, as well as nutrition drugs, among others. The firm's products include nimesulide granules, cefminox sodium for injection, Zhike Juhong granules, Ganmao Qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, Jianerle granules, pediatric four vitaminsand calcium gluconate granules, as well as ribavirin pellets and Norfloxacin capsules for adults.
See Also
What is Honz Pharmaceutical Co Ltd's Other Current Liabilities?
Other Current Liabilities
167.3m
CNY
Based on the financial report for Sep 30, 2025, Honz Pharmaceutical Co Ltd's Other Current Liabilities amounts to 167.3m CNY.
What is Honz Pharmaceutical Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
15%
Over the last year, the Other Current Liabilities growth was 63%. The average annual Other Current Liabilities growth rates for Honz Pharmaceutical Co Ltd have been 27% over the past three years , 9% over the past five years , and 15% over the past ten years .
